Cipla moves against NPPA for price fixation of asthma drugs; DOP junks plea Farhat Nasim16 Jun 2019 6:14 AMNew Delhi: Mumbai-based drugmaker, Cipla Limited's review petition against the Government regulatory agency, National Pharmaceutical Pricing Authority...
Cipla, Pulmatrix join hands to co-develop Pulmazole for treating asthma Garima16 April 2019 4:10 AMPulmazole an inhaled iSPERSE formulation of the antifungal drug itraconazole for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in...
Cipla signs over Rs 152 crore pact with Pulmatrix for new asthma drug Pulmazole Garima2 April 2019 4:15 AMThe agreement has been signed between the company's wholly-owned subsidiary in the US, Cipla Technologies LLC with Pulmatrix Inc for investment in...
HC Rescues Lupin on Price cap on powdered form of asthma drug Ruby Khatun Khatun22 April 2018 6:28 AMNew Delhi: The Delhi High Court directed the Centre not to take any coercive measure against Indian pharma major Lupin Ltd which has challenged a...
Morepen Labs gets USFDA nod for asthma drug Ruby Khatun Khatun21 Dec 2017 8:39 AMNew Delhi: Morepen Laboratories said the US health regulator has given approval to Montelukast Sodium, used in managing asthma symptoms and seasonal...
Regeneron, Sanofi asthma drug data fails to excite investors Ruby Khatun Khatun13 Sept 2017 8:12 AMPARIS: Shares of Regeneron Inc and Sanofi SA slid on Monday after late-stage trial data for their asthma drug, dupilumab, fell short of investor...
